Skip to content
Medical Health Aged Care

General practice nurses could be key to better contraception and abortion care

Monash University 3 mins read

A significant opportunity to increase women’s access to the most effective form of contraception and abortion care is being missed in Australia, according to new research from Monash University’s SPHERE Centre of Research Excellence.

A comprehensive study, published in the Journal of Advanced Nursing, reveals practice nurses – registered or enrolled nurses working within a general practice setting – are underutilised when it comes to advice, and treatment, for patients about long-acting reversible contraceptives (LARCs).

A second study from the same research, also published in the Journal of Advanced Nursing, reveals similar results.

The online survey involved about 500 practice nurses, most of whom were women working as registered nurses in metropolitan settings.

The study’s lead author and SPHERE Research Fellow, Dr Sharon James, said Australia’s 14,500 practice nurse workforce lacks the necessary structural support to provide LARCs or medical abortion.

“We found that practice nurses whose primary workplace was general practice were less likely to provide LARC or medication abortion services than those working in other settings, such as family planning organisations or women’s health services,” Dr James said.

Dr James said not enough general practitioners and other health practitioners are providing contraception and abortion care. “Any way we can extend the number of providers increases women’s access to this care.” 

In the studies, practice nurses felt their support could assist patients to make informed decisions about their contraceptive choices (90.4 per cent) and support medical abortion (71 per cent), yet structural issues such as funding, education and service normalisation impact practice. 

But few respondents were currently providing insertion or removal of intrauterine devices (IUDs) (11.2 per cent) or implants (15.9 per cent), and very few were involved in abortion care (8.6 per cent).

“Supportive policy, funding and training arrangements are needed to support practice nurses to provide LARC and medical abortion services in general practice settings,” Dr James said.

“Practice nurses are highly skilled and an important workforce to help expand women’s access to LARC and medical abortion. Further education and training, health system organisation, policy and funding initiatives are needed to maximise this opportunity.”

In Australia, almost a third (30.4 per cent) of all unintended pregnancies end in abortion, with women in rural and regional areas 1.4 times more likely to experience an unintended pregnancy than women in metropolitan settings. Also, contraceptive use in Australia is skewed towards less effective forms of contraception, such as oral contraceptives (37.2 per cent) and condoms (33.9 per cent). 

Dr James said strengthening practice nurse training and roles in LARC and medical abortion care aligns with national workforce and public health initiatives to support patient choice.

“The Federal Government’s budget announcement of $25 million to establish LARC training centres for health professionals, including in regional and remote areas, will assist in meeting training needs,” Dr James said. “Deregulation of medical abortion by the Therapeutic Goods Administration has supported better access, allowing prescribing by  nurse practitioners and endorsed midwives.”

Dr James said that most practice nurses were open to providing abortion care, but this was limited by the knowledge and confidence to do so and compounded by concerns about the stigma surrounding abortion care. 

“Normalisation of abortion care as part of nursing education and routine practice would support its provision.” 

Read the full papers in the Journal of Australian Nursing: Practice Nurse Provision of Long-Acting Reversible Contraception: A Cross-Sectional Survey of Knowledge and Practices and The Knowledge, Attitudes and Practices of Practice Nurses in the Provision of Medication Abortion: A Cross-sectional Survey.

DOI: 1.  https://doi.org/10.1111/jan.17020 2. https://doi.org/10.1111/jan.17051

 

For media enquiries please contact:

 

Monash University

Helena Powell – Media Advisor (medical)
E: [email protected] 

T: +61 (0) 474 444 171

 

For more Monash media stories, visit our news and events site  


For general media enquiries please contact:
Monash Media
E: [email protected]
T: +61 (0) 3 9903 4840

More from this category

  • Medical Health Aged Care, Research Development
  • 11/07/2025
  • 16:28
The Florey

Harnessing mRNA to prevent and slow Alzheimer’s disease

mRNA Victoria funds 2Floreyprojects to prevent and treat Alzheimer’s disease Key points mRNA Victoria has funded 2 Alzheimer’s disease research projects that could position Victoria as a leader in the development of mRNA-based therapies. Dr Abdel Belaidi will develop an mRNA-based system that crosses the blood-brain barrier and aims to slow or even halt disease progression. Dr Rebecca Nisbet will develop an mRNA vaccine that aims to prevent Alzheimer’s disease from developing. Florey researchers working at the cutting edge of dementia research have received funding from mRNA Victoria to develop treatments and a vaccine for Alzheimer’s disease. Since mRNA vaccines…

  • Medical Health Aged Care
  • 11/07/2025
  • 07:05
Royal Australian College of GPs

GPs urge Tasmanian families to get vaccinated against whooping cough and call for free shots to reduce barriers

The Royal Australian College of GPs (RACGP) is urging Tasmanian families to get vaccinated against pertussis, or ‘whooping cough’ and called on all parties and candidates running in the state election to commit to making the vaccination free for all patients. From 1 January 2024 to April 2025, 1238 whooping cough cases were notified in Tasmania, including 10 infants aged under six months. Most hospitalisations and deaths occur in this group, who are not old enough to have received all vaccine doses. More than 21,000 infections were recorded nationwide last year, compared to just 2450 in 2023, and the National…

  • Contains:
  • General News, Medical Health Aged Care
  • 11/07/2025
  • 07:00
La Trobe University

La Trobe researchers awarded $4.5 million in ARC Future Fellowships

LaTrobe University researchers have secured almost $4.5 million in Federal Government funding to further studies into areas such as immune cell development, Australian history and agriculture. Four researchers received an Australian Research Council (ARC) Future Fellowship 2025. The prestigious Future Fellowships support high quality research in areas of national and international benefit, including in national research priorities. Dr Lisa Mielke, from the School of Cancer Medicine, the La Trobe Institute of Molecular Science (LIMS) and the Olivia Newton-John Cancer Research Institute (ONJCRI), received $1.13 million to identify new molecules for future drug and vaccine development to improve gut health in…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.